Helen Louise Collins
CHIEF MEDICAL OFFICER; Director · 12 filings · Latest: Sep 17, 2026
Enliven Therapeutics, Inc.
Kura Oncology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Sep 17, 2026 | Sale | $50.35 | 5,000 | $251.8K | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Sep 17, 2026 | Option Exercise | $2.48 | 5,000 | $12.4K | 30,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Aug 17, 2026 | Sale | $58.59 | 5,000 | $292.9K | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Aug 17, 2026 | Option Exercise | $2.48 | 5,000 | $12.4K | 30,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Jul 17, 2026 | Sale | $52.67 | 5,000 | $263.4K | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Jul 17, 2026 | Option Exercise | $2.48 | 5,000 | $12.4K | 30,000 | |
ELVN | Collins Helen Louise | — | Jul 17, 2026 | Proposed Sale | $50.86 | 15,000 | $762.9K | — | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Jun 17, 2026 | Sale | $43.80 | 5,000 | $219.0K | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Jun 17, 2026 | Option Exercise | $2.48 | 5,000 | $12.4K | 30,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | May 18, 2026 | Sale | $39.79 | 5,000 | $199.0K | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | May 18, 2026 | Option Exercise | $2.48 | 5,000 | $12.4K | 30,000 | |
ELVN | Collins Helen Louise | — | May 18, 2026 | Proposed Sale | $41.34 | 15,000 | $620.1K | — | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Apr 17, 2026 | Sale | $47.67 | 5,000 | $238.4K | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Apr 17, 2026 | Option Exercise | $2.48 | 5,000 | $12.4K | 30,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Mar 25, 2026 | Sale | $35.10 | 40,000 | $1.4M | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Mar 25, 2026 | Option Exercise | $2.48 | 40,000 | $99.2K | 65,000 | |
ELVN | Collins Helen Louise | — | Mar 25, 2026 | Proposed Sale | $31.15 | 45,000 | $1.4M | — | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Mar 17, 2026 | Sale | $27.76 | 5,000 | $138.8K | 25,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Mar 17, 2026 | Option Exercise | $2.48 | 5,000 | $12.4K | 30,000 | |
ELVN | Helen Louise Collins | CHIEF MEDICAL OFFICER | Mar 10, 2026 | Sale | $30.19 | 10,129 | $305.8K | 25,000 |
Page 1 of 2
Next →